Study: Viagra May Be Tested for Treatment of Rare Cancers

April 13, 2018

(UPI) – Drugs that are prescribed to treat erectile dysfuction, including Viagra, Cialis and Levitra, may be tested to treat rare forms of cancer, according to a new study. Researchers have identified selective phosphodiesterase 5, or PDE5, inhibitors that have the potential to be used in new cancer drug trials. The Repurposing Drugs in Oncology project, an international collaboration between the Anticancer Fund, Belgium and USA-based GlobalCures, published the study Wednesday in the journal Ecancermedicalscience.

Recommended Reading